Author | Michael J. Guarino, MD | OncLive

Author | Michael J. Guarino, MD

Articles

Dr. Guarino on IMMU-132 in Advanced Metastatic Lung Cancer

June 26, 2015

Video

Michael J. Guarino, MD, senior staff member, Christiana Care's Department of Medicine, partner, Medical Oncology Hematology Consultants, Christiana Care's Helen F. Graham Cancer Center, discusses initial data from a phase I/ll study examining an anti-ΤROP-2-SN-38 antibody-drug conjugate, sacituzumab govitecan (IMMU-132), as therapy for advanced metastatic lung cancer.

x